<?xml version="1.0"?>
<metadata xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/"><dc:title>Glucagon-like peptide 1 and taste perception</dc:title><dc:creator>Jensterle Sever,	Mojca	(Avtor)
	</dc:creator><dc:creator>Rizzo,	Manfredi	(Avtor)
	</dc:creator><dc:creator>Janež,	Andrej	(Avtor)
	</dc:creator><dc:subject>glucagon-like peptide 1 (GLP-1)</dc:subject><dc:subject>taste</dc:subject><dc:subject>tongue</dc:subject><dc:subject>obesity</dc:subject><dc:subject>sweet</dc:subject><dc:description>Preclinical studies provided some important insights into the action of glucagon-like peptide 1 (GLP-1) in taste perception. This review examines the literature to uncover some molecular mechanisms and connections between GLP-1 and the gustatory coding. Local GLP-1 production in the taste bud cells, the expression of GLP-1 receptor on the adjacent nerves, a functional continuum in the perception of sweet chemicals from the gut to the tongue and an identification of GLP-1 induced signaling pathways in peripheral and central gustatory coding all strongly suggest that GLP-1 is involved in the taste perception, especially sweet. However, the impact of GLP-1 based therapies on gustatory coding in humans remains largely unaddressed. Based on the molecular background we encourage further exploration of the tongue as a new treatment target for GLP-1 receptor agonists in clinical studies. Given that pharmacological manipulation of gustatory coding may represent a new potential strategy against obesity and diabetes, the topic is of utmost clinical relevance.</dc:description><dc:date>2021</dc:date><dc:date>2022-02-14 08:30:05</dc:date><dc:type>Članek v reviji</dc:type><dc:identifier>134959</dc:identifier><dc:identifier>UDK: 616.379</dc:identifier><dc:identifier>ISSN pri članku: 1422-0067</dc:identifier><dc:identifier>DOI: 10.3390/ijms22020902</dc:identifier><dc:identifier>COBISS_ID: 47378691</dc:identifier><dc:language>sl</dc:language></metadata>
